J Haem Pract 2016; 3(1):4,5. doi: 10.17225/jhp00072

Authors: Michael Laffan

Professor Michael Laffan
Centre for Haematology, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK. Email:


In a recent editorial published in Haemophilia, Carolyn Millar asked ‘Why and how do we classify von Willebrand disease?’ [1]. This may seem like a philosophical question, but two case reports in this edition of The Journal of Haemophilia Practice illustrate good practical answers to both parts of the question.


This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited




  1. Millar C. Why and how do we classify von Willebrand disease? Haemophilia 2015; 21(4): 407-10. doi: 10.1111/hae.12725.
  2. Laffan MA, Lester W, O’Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling DM. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167(4): 453-65. doi: 10.1111/bjh.13064.
  3. Rashid S, Bignell P, Keeling D, Curry N. Management of an uncommon form of type 2M VWD: a single centre experience. J Haem Pract 2016; 3(1). doi: 10.17225/jhp00065
  4. Fosbury E, Blumberg R, Liesner R, Sibson K. Lessons from a neonate with unusual bleeding. J Haem Pract 2016; 3(1). doi: 10.17225/jhp00064

The Journal of Haemophilia Practice is published by Haemnet.

Haemnet is a registered charity that brings together and gives a voice to haemophilia nurses, physiotherapists and allied health care professionals, providing forums for collaborative research, educational activities and support.